Patents/Assignees

Wntrx Pharmaceuticals Inc.

2 patents in portfolio

US12264185utility2025
Stabilized BCL9 Peptides for Treatment of Aberrant Wnt Signaling
0 cites
US11591365utility2023
BCL9 Peptides and Variants Thereof
0 cites